Virtu Financial’s Protara Therapeutics TARA Stock Holding History

Virtu Financial’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$53K	Sell	10,212 -58,744	-85%	-$348K	﹤0.01%	1280
2025 Q4	$368K	Buy	+68,956	New	+$383K	0.01%	752
2022 Q4	–	Sell	-12,465	Closed	-$37K	–	2118
2022 Q3	$37K	Buy	12,465 +2,362	+23%	+$8K	﹤0.01%	1266
2022 Q2	$30K	Buy	+10,103	New	+$36.9K	﹤0.01%	1249
2021 Q4	–	Sell	-17,130	Closed	-$119K	–	2158
2021 Q3	$119K	Buy	+17,130	New	+$134K	0.01%	1089
2019 Q4	–	Sell	-2,259	Closed	-$23K	–	1833
2019 Q3	$23K	Buy	+2,259	New	+$32.3K	﹤0.01%	1277
2018 Q4	–	Sell	-353	Closed	-$28K	–	1972
2018 Q3	$28K	Buy	+353	New	+$32.6K	﹤0.01%	1375
2018 Q2	–	Sell	-369	Closed	-$37K	–	2482
2018 Q1	$37K	Buy	+369	New	+$33.6K	﹤0.01%	1759
2017 Q4	–	Sell	-293	Closed	-$23K	–	2991
2017 Q3	$23K	Buy	+293	New	+$16.8K	﹤0.01%	2332

Other funds holding TARA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Virtu Financial's TARA Position: Q1 2026 in Review

Virtu Financial reduced its Protara Therapeutics (TARA) stake by 85% in Q1 2026, selling an estimated $348K and leaving 10,212 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Virtu Financial first reported a position in TARA in Q3 2017 and has held it in 9 quarters since. The position peaked at $368K in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

Virtu Financial held 10,212 shares of Protara Therapeutics worth $53K as of Q1 2026.
Virtu Financial sold 58,744 Protara Therapeutics shares in Q1 2026, an estimated $348K.
Protara Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1280 holding.
Virtu Financial first reported a position in Protara Therapeutics in Q3 2017 and has held it in 9 quarters since.
Virtu Financial's Protara Therapeutics position peaked at $368K in Q4 2025.
114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.